Centrifugal Blood Pump Market

Centrifugal Blood Pump Market Size and Growth Analysis

The global centrifugal blood pumps market exhibits a promising path for growth. It was observed that the market operates within a dynamic environment influenced by factors like technological progress, shifting demographics, and healthcare policies. The market is driven by several converging factors such rising prevalence of cardiovascular diseases, shift towards minimally invasive cardiac surgeries (MICS), and growing demand for blood pumps in organ transplant procedures, continuous innovation in pump design and functionality, increasing adoption of portable and compact centrifugal blood pumps. The market is determined by robust competition, prompting key players to emphasize product innovation and strategic partnerships. Ongoing research and development endeavors are pivotal drivers for the market's expansion.

Centrifugal Blood Pump Market Size

Report	Details
Market Size Value	USD 137.6 Million in 2025
Market Size Value	USD 210.6 Million by 2033
CAGR	5.3%
Forecast Period	2025-2033
Base Year	2023
Historic Data	2020
Forecast Units	Value (USD Million/USD Billion)
Segments Covered	Application, End User and Region
Geographics Covered	North America, Latin America, Europe, Asia-Pacific, Middle East & Africa

For example Getinge revealed its acquisition of the entire share capital of Healthmark Industries Co. Inc., a prominent US-based company specializing in inventive instrument care and infection control consumables. The transaction, valued at approximately USD 320 million, signifies a strategic move to strengthen Getinge's footprint in sterile reprocessing within the United States while simultaneously enabling Healthmark to extend its global reach.

Collaborations with healthcare entities, research institutions, and stakeholders are instrumental in accelerating innovation and market penetration. The potential of centrifugal blood pumps extends beyond their current applications, promising utility in organ transplantation and pediatric cardiac surgeries. In recent years, however, the landscape has seen the emergence of nimble. It was observed that specialized players like Leviticus Cardio, Jarvik Heart, and BiVACOR, each bringing novel technologies and design approaches to the table. These new entrants aim to address challenges associated with traditional pumps, such as durability, size, and compatibility.

A centrifugal pump is a mechanical device designed to move a fluid by means of the transfer of rotational energy from one or more driven rotors, called impellers.  Fluid enters the rapidly rotating impeller along its axis and is cast out by centrifugal force along its circumference through the impeller’s vane tips. It is utilized in surgical procedures and temporary support for heart failure patients. This mechanism ensures adequate oxygenation and nutrient supply to vital organs.

The market growth is propelled by increased demand for blood pumps in cardiac surgeries, organ transplants, and ECMO procedures. Advancements in technology and the rising adoption of minimally invasive techniques further contribute to this momentum. While North America and Europe currently dominate, the Asia-Pacific region is poised for rapid growth due to a burgeoning population with escalating healthcare expenditure.

Future Growth Insights on the Centrifugal Blood Pumps Market

In coming future, the escalating rates of heart failure and cardiovascular diseases will drive the demand for cardiac support devices, with centrifugal blood pumps finding expanded applications beyond traditional cardiac surgery. This includes roles in organ transplants, lung support, and critical care settings. Miniaturization, enhanced biocompatibility, quieter operation, and integration of AI features are elevating pump performance, fostering market adoption. Focusing on continual miniaturization, biocompatibility improvement, AI integration, and remote monitoring can enhance pump efficacy and patient outcomes.

As the global population ages, the susceptibility to CVDs significantly rises, resulting in an increased demand for centrifugal blood pumps, particularly in geriatric patients undergoing cardiac procedures. Further advancements in centrifugal blood pump technology will contribute to the development of more efficient, miniaturized, biocompatible, and durable pumps. These enhancements will not only improve patient outcomes but also stimulate market adoption.

The rising popularity of minimally invasive cardiac surgeries (MICS), attributed to faster recovery times and reduced trauma for patients will drive the demand for centrifugal blood pumps market. Their smaller size and gentler impact on blood make them well-suited for MICS, further boosting market demand. Government initiatives and favorable reimbursement policies, influenced by growing awareness of CVDs and technological advancements in blood pumps will also contribute to the market growth.

Latest Developments in the Centrifugal Blood Pumps Market: Expansions, Partnerships, and Innovations

Abbott | New product development to accelerate innovation

Abbott introduced two new authorization from the U.S. Food and Drug Administration (FDA) for the company's notable life care system. With the new indication, the CentriMag Blood Pump for use with the CentriMag System, is cleared for longer-term use in adults when extracorporeal membrane oxygenation (ECMO) – a type of life support for people whose heart and lungs are not working – is critical to saving their life. Now, the clearance for longer-term support allows physicians more time to assess next steps and make critical care decisions for their patients.

Eurosets | Strategic partnerships to contribute for market growth

Eurosets and Estor revealed a key partnership for the exclusive distribution of Polymyxin B hemoperfusion therapy in European countries such as France, Belgium, Netherlands, Luxemburg and Austria. This strategic partnership will further lead to the development of Polymyxin B hemoperfusion therapy in the area of post-cardiac surgery as well as in the general intensive care so that Polymyxin B hemoperfusion can be obtainable to a substantial patient population across Europe.

LivaNova | Technological developments and market penetration

LivaNova PLC, a prominent medical technology firm, disclosed that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for extracorporeal membrane oxygenation (ECMO) for its advanced circulatory support pump and controller system, LifeSPARC™. The clearance was facilitated by utilizing real-world evidence, including data gathered during the COVID-19 pandemic, showcasing the company's commitment to advancing medical solutions through robust and relevant information.

Centrifugal Blood Pumps Market: Latest and Evolving Trends

Current Market Trends

The centrifugal blood pump market is undergoing substantial growth and evolving dynamics, primarily driven by the increasing global prevalence of cardiovascular diseases (CVDs). This upswing in CVD cases propels the demand for diverse cardiac interventions, including surgeries, where centrifugal blood pumps play a pivotal role. Additionally, these pumps find applications in Ventricular Assist Devices (VADs) for heart failure patients and Extracorporeal Membrane Oxygenation (ECMO) for critically ill individuals facing respiratory or cardiac failure. The growing incidence of these medical conditions further amplifies the expansion of the market.

Rising awareness about CVDs and their associated risk factors prompts proactive measures and early detection, leading to more timely interventions involving blood pumps. This proactive approach contributes to the overall market growth. The increasing demand for blood pumps serves as a catalyst for research and development efforts, fostering innovations such as miniaturization, enhanced biocompatibility, and quieter operation. These advancements not only enhance patient outcomes but also broaden the appeal to a wider patient demographic, thereby driving market expansion.

Market Opportunity - Increasing investments in healthcare infrastructure

Rising investment in healthcare infrastructure frequently leads to the establishment and enhancement of distribution networks. This can culminate in enhanced accessibility and availability of centrifugal blood pump across a spectrum of healthcare facilities, pharmacies, and wellness centers. Upgraded healthcare infrastructure typically encompasses initiatives aimed at fostering consumer awareness and education. This, in turn, can cultivate a more knowledgeable consumer base regarding the advantages of centrifugal blood pump, potentially fostering increased demand as individuals become more health-conscious. Investments in healthcare infrastructure may foster collaborative ventures and partnerships between nutraceutical gummy manufacturers and healthcare institutions. Such partnerships can engender joint initiatives, promotional campaigns, and the seamless integration of centrifugal blood pump into healthcare programs, thereby amplifying their visibility.

Evolving Trends

Financial commitments to healthcare infrastructure may also encompass enhancements in regulatory frameworks and elevations in quality standards. This can prove advantageous for the centrifugal blood pump market by ensuring adherence to health and safety regulations, elevating product quality, and instilling trust among consumers. A fortified healthcare infrastructure can establish a conducive environment for research and development in the nutraceutical industry, potentially resulting in innovations in gummy formulations, the introduction of novel ingredients, and the crafting of products tailored to specific health concerns.

Centrifugal Blood Pumps Market: Emerging Investment Highlights

Investments in healthcare infrastructure frequently encompass the implementation of health and wellness programs. Given the convenience and appeal of centrifugal blood pump, these products may seamlessly integrate into such programs, further propelling their consumption as a component of a wholesome life. Financial backing for healthcare infrastructure may kindle collaborations between nutraceutical gummy manufacturers and pharmaceutical companies. Such collaborations can lead to the creation of specialized formulations amalgamating the benefits of pharmaceuticals and nutraceuticals, thereby broadening the market reach. The amelioration of healthcare infrastructure in diverse regions can pave the way for the global expansion of the centrifugal blood pump market.

As healthcare facilities become more adept at advocating and facilitating preventive health measures, the demand for nutraceutical products may experience a surge on a global scale. Financial investments in healthcare infrastructure often involve the assimilation of telehealth services and e-commerce platforms. This integration can simplify access to centrifugal blood pump through online channels, making them more easily accessible to consumers in search of convenient health solutions.

Hence, the escalating investment in healthcare infrastructure holds the potential to establish a conducive environment for the Market. Spanning from enhanced accessibility and consumer awareness to collaborations and advancements in research, these developments can play a pivotal role in the overall growth and seamless integration of centrifugal blood pump into evolving healthcare ecosystems.

Centrifugal Blood Pumps Market Limitation

Expensive cost as well as alternative treatment options

The significant challenge confronting the centrifugal blood pump market arises from the elevated costs associated with these pumps and the existence of alternative treatment options. This challenge not only impedes the market's growth but also has repercussions on its accessibility. Centrifugal blood pumps, characterized by intricate manufacturing processes, incur substantial initial expenses. Such financial demands can pose a considerable burden for both patients and healthcare systems, potentially limiting the market's outreach and hindering widespread adoption. The exorbitant costs may create barriers to entry in developing countries and regions with constrained healthcare budgets, further constricting the market's scope.

Market Fragmentation

The competitive landscape for centrifugal blood pumps is dynamic and characterized by a mix of established players and innovative entrants, all vying for prominence in the rapidly evolving field of cardiac assist devices. Key industry leaders such as Medtronic, Abbott Laboratories, and Terumo Corporation have historically dominated the market, leveraging their extensive research and development capabilities, regulatory expertise, and global distribution networks. These companies offer a range of centrifugal blood pumps designed for various clinical applications, including short-term and long-term circulatory support.

In recent years, however, the landscape has seen the emergence of nimble and specialized players like Leviticus Cardio, Jarvik Heart, and BiVACOR, each bringing novel technologies and design approaches to the table. These new entrants aim to address challenges associated with traditional pumps, such as durability, size, and compatibility.

Potential Threats

Global centrifugal pumps market confronts a threat from supply chain issues, high cost, alternative treatments, volatile oil and gas prices and cavitation. The advent of new technologies in cardiac support, such as implantable miniaturized pumps or regenerative therapies, could pose enduring challenges to the prevailing market dominance of centrifugal blood pumps. The COVID-19 pandemic resulted to the supply chain challenges that influenced the centrifugal pump market.

Regulatory Compliance

Anticipating potential regulatory measures aimed at ensuring the cost-effectiveness and affordability of medical devices, manufacturers face the additional challenge of maintaining competitive pump prices. The evolving landscape of healthcare, marked by a growing emphasis on sustainability and value-based care, exerts pressure on hospitals and insurers to prioritize cost-effective options over pricier technologies like centrifugal pumps.

Drivers:

• Rising prevalence of cardiovascular diseases
• Shift towards minimally invasive cardiac surgeries (MICS)
• Rising demand for blood pumps in organ transplant procedures
• Continuous innovation in pump design and functionality
• Increasing adoption of portable and compact centrifugal blood pumps

Opportunities:

• Increasing investment on healthcare infrastructure
• Increasing use of centrifugal blood pumps in ECMO procedures

Restraints

• Expensive cost as well as alternative treatment options

Centrifugal Blood Pump Market Segmentation Highlights

By Application - Cardiopulmonary Bypass (CPB) application accounted for the largest revenue share

The application segment of the global centrifugal blood pump market is diverse and plays a crucial role in various medical scenarios. These pumps find extensive use in Cardiopulmonary Bypass (CPB), Extracorporeal Life Support (ECLS), Ventricular Assist Devices (VADs), Bridge to Recovery, High-Risk Percutaneous Coronary Interventions (PCI), Short-Term Circulatory Support, Minimally Invasive Cardiac Procedures, Pediatric Cardiac Support, Hemodialysis, Blood Salvage, and Auto-transfusion. Additionally, they contribute significantly to Research & Development in the medical field. The versatility of centrifugal blood pumps makes them indispensable in various medical applications, ensuring efficient and reliable circulatory support across diverse clinical settings.

Cardiopulmonary bypass (CPB) is a technique in which a machine temporarily takes over the function of the heart and lungs during cardiac surgery, maintaining the circulation of blood and oxygen to the body. The CPB pump itself is often referred to as a heart-lung machine or "the pump". Cardiopulmonary bypass pumps are operated by perfusionists. CPB is a form of extracorporeal circulation. Extracorporeal membrane oxygenation (ECMO) is generally used for longer-term treatment.

The global surge in the utilization of Cardiopulmonary Bypass (CPB) procedures has led to a significant impact on the medical technology landscape, particularly with the growing prominence of the centrifugal blood pump. In the treatment of cardiopulmonary bypass, the centrifugal blood pump plays a crucial role within the extracorporeal circuit, contributing to improved patient outcomes and driving advancements in the field. Around 620 million people are living with heart and circulatory diseases across the world. Each year around 60 million people across the world develop a heart or circulatory disease.

The primary role of the centrifugal blood pump in cardiopulmonary bypass is to facilitate the continuous circulation of blood throughout the extracorporeal circuit. Its design, characterized by a rotating impeller within a sealed chamber, generates a non-pulsatile flow, minimizing trauma to blood components and reducing the risk of hemolysis. This technology ensures effective oxygenation and carbon dioxide removal, supporting the heart and lungs during surgical interventions

By End User - Hospitals dominated the Centrifugal Blood Pumps end user market

The end-user segment of the global centrifugal blood pump market encompasses a range of healthcare facilities, each contributing to the widespread adoption of this vital technology. Hospitals, as primary healthcare institutions, play a significant role in utilizing centrifugal blood pumps for various applications. Specialty Clinics, with their focus on specific medical areas, leverage these pumps to provide targeted care. Ambulatory Surgical Centers, known for their efficiency and outpatient services, also incorporate centrifugal blood pumps into their procedures.

Additionally, other healthcare facilities further contribute to the market's reach. The adoption of centrifugal blood pumps across diverse end-user segments underscores their importance in enhancing medical interventions and patient care across a spectrum of healthcare settings.

The global increase in the number of hospitals serves as a significant driver for the Centrifugal Blood Pumps market. Hospitals are key end-users of these critical medical devices, utilizing Centrifugal Blood Pumps in various medical procedures, particularly in cardiovascular surgeries and interventions. The growing prevalence of cardiovascular diseases and the expanding need for advanced medical technologies contribute to the rising demand for Centrifugal Blood Pumps within hospital settings. As more hospitals are established and existing healthcare facilities undergo expansions or upgrades, there is a proportional increase in the adoption of Centrifugal Blood Pumps to meet the demands of modern cardiac care.

This surge in hospital infrastructure development globally creates a conducive environment for the sustained growth of the Centrifugal Blood Pumps market, ensuring that these vital devices continue to play a central role in supporting cardiovascular treatments within hospital settings.

Regional Insights

North America

The North American Centrifugal Blood Pump Market is experiencing significant growth, and several factors contribute to its expansion. North America Centrifugal Blood Pump market is valued at USD 54.9 Million in 2024 growing at a CAGR of 4.2% for 2025 to 2033. One major driving force is the increasing prevalence of cardiovascular diseases in the region. North America faces a rising burden of heart-related ailments, including heart failure, coronary artery disease, and other cardiac conditions. As a result, there is a growing demand for advanced and efficient circulatory support systems, such as centrifugal blood pumps. The technological advancements in centrifugal blood pump design and functionality also play a crucial role in propelling the market forward.

Ongoing research and development efforts have led to innovations that enhance the performance, durability, and safety of centrifugal blood pumps. These improvements contribute to the adoption of centrifugal blood pump systems by healthcare providers across North America, as they seek cutting-edge solutions for cardiac support and patient care.

Moreover, the region's well-established healthcare infrastructure and a robust healthcare expenditure framework further facilitate the integration of centrifugal blood pumps into clinical practice. The availability of skilled medical professionals and a supportive regulatory environment contribute to the successful adoption of these advanced medical devices. The collaborative efforts of industry players, healthcare institutions, and regulatory bodies collectively foster a conducive ecosystem for the growth of the Centrifugal Blood Pump Market in North America.

Europe

In Europe, the Centrifugal Blood Pump market is characterized by a combination of factors contributing to its growth and prominence. The region boasts a well-established healthcare infrastructure and a strong emphasis on technological innovation in the medical field. The prevalence of cardiovascular diseases, particularly in an aging population, has driven the demand for advanced cardiac support systems, making centrifugal blood pumps integral in managing and treating heart-related conditions.

Each European country contributes uniquely to the market dynamics. Germany, as an economic powerhouse plays an essential role, with its commitment to research and development, healthcare investments, and technological advancements. France, known for its robust healthcare system, focuses on addressing the increasing burden of cardiovascular diseases through the adoption of innovative medical technologies.

Asia Pacific

The Asia Pacific Centrifugal Blood Pump market is influenced by a diverse set of factors contributing to its growth and development. The region's economic growth, coupled with an expanding middle-class population, has increased the affordability and accessibility of advanced medical technologies, including centrifugal blood pumps. The rising prevalence of life-related diseases, such as diabetes and hypertension, across various demographics in Asia Pacific, drives the demand for effective cardiac support systems.

Middle East & Africa

In the Middle East and Africa (MEA), a major driving factor for the Centrifugal Blood Pump market is the increasing prevalence of cardiovascular diseases. The region is witnessing a rise in the incidence of heart-related ailments, driven by factors such as life changes, aging populations, and the increasing prevalence of risk factors like diabetes and hypertension. As cardiovascular diseases become more prevalent in the MEA region, there is a growing demand for advanced cardiac support systems, including centrifugal blood pumps. These devices play a crucial role in managing and treating cardiovascular conditions, offering circulatory support during cardiac surgeries and procedures.

Centrifugal Blood Pumps Market: Top Key Players and Competitive Ecosystem

Collaborations between established medical device companies and startups, as well as strategic partnerships with research institutions, contribute to the competitive intensity. The ongoing quest for miniaturization, improved energy efficiency, and enhanced biocompatibility remains a focal point for all players in this space. As the demand for advanced cardiac support systems continues to grow, the centrifugal blood pump market is poised for further innovation and competition, with companies striving to redefine the standard of care for patients with cardiovascular diseases.

As technological advancements continue to drive innovation in cardiovascular care, these companies are likely to engage in continuous research and development efforts, striving to enhance the performance, efficiency, and safety of centrifugal blood pumps for better patient outcomes

Key Market Players

Major vendors in the Global Centrifugal Blood Pump market are Abbott, Braile Biomédica Ltd., Eurosets, Getinge AB (Getinge), Harvard Apparatus, Hugo Sachs Elektronik (HSE), Jarvik Heart, Inc., LivaNova PLC, Medtronic, SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. (MERA), Terumo Corporation, Xenios AG (Fresenius Medical Care Company) and Others.

Advancements and Innovations in the Centrifugal Blood Pumps Sector (2024-2025)

Abbott Laboratories has solidified its position as a leader in the sector with pivotal updates to its CentriMag Blood Pump. In 2024, the company secured two FDA clearances for this life-saving device, allowing extended use in adults requiring extracorporeal membrane oxygenation (ECMO) during critical care scenarios. These approvals highlight the pump's enhanced capabilities and reliability in delivering circulatory support during emergencies.

Alongside these regulatory milestones, Abbott introduced the CentriMag Pre-connected Pack, an innovative solution designed to streamline the system setup process. This enhancement has simplified deployment in hospital settings, ensuring timely and efficient patient care.

Another major player, LivaNova PLC, has advanced the field with its LifeSPARC system. In 2024, the company achieved FDA 510(k) clearance for this next-generation pump and controller designed specifically for ECMO applications.

The clearance process was supported by real-world data collected during the COVID-19 pandemic, showcasing the adaptability and efficacy of the system under challenging conditions. This development underscores LivaNova’s dedication to addressing the complexities of critical care and advancing the capabilities of ECMO technology.

The sector has also been marked by advanced innovations in the design and functionality of centrifugal blood pumps. In 2025, researchers unveiled new wearable and portable models that promise to revolutionize patient care for individuals with heart failure. These advanced pumps feature innovative engineering, including parallel inlet and outlet pipes and ring cavities optimized for superior fluid dynamics.

Segmentations Analysis of Centrifugal Blood Pumps Market: -

Major Segmentations Are Distributed as follows:

• By Application
  • Cardiopulmonary Bypass (CPB)
  • Extracorporeal Life Support (ECLS)
  • Ventricular Assist Devices (VADs)
  • Bridge to Recovery
  • High-Risk Percutaneous Coronary Interventions (PCI)
  • Short-Term Circulatory Support
  • Minimally Invasive Cardiac Procedures
  • Pediatric Cardiac Support
  • Hemodialysis
  • Blood Salvage and Auto-transfusion
  • Research & Development
  • Other
• By Type
  • Electrical
  • Mechanical
• By End-User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific

• • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific

• • Middle East & Africa

• • Saudi Arabia
  • UAE
  • South Africa
  • Nigeria
  • Egypt
  • Israel
  • Turkey
  • Rest of MEA

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.

Report Answers Following Key Questions:

• What will be the Centrifugal Blood Pumps Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the Centrifugal Blood Pumps Market?
• What are the main forces behind worldwide Centrifugal Blood Pumps Market? Which companies dominate Centrifugal Blood Pumps Market?
• Which companies dominate Centrifugal Blood Pumps Market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global Insight Engines industry's suppliers' opportunities and dangers in Centrifugal Blood Pumps Market?
• What is the industry's regional sales, income, and pricing analysis? In the Centrifugal Blood Pumps Market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Centrifugal Blood Pumps Market?

Frequently Asked Questions (FAQ)

What is the value of Centrifugal Pumps Market?

• In 2024, the Centrifugal Blood Pumps Market was valued USD 130.8 Million

Which region holds the largest centrifugal blood pumps market share?

• North American Centrifugal Blood Pump Market holds the major market share of 42.2% in 2024 due to the increasing prevalence of cardiovascular diseases in the region. The market is experiencing significant growth, and several factors contribute to its expansion

Who are the major players in centrifugal blood pumps market?

• Major players in the market include Abbott, Braile Biomédica Ltd., Eurosets, Getinge AB (Getinge), Hugo Sachs Elektronik (HSE), LivaNova PLC, Medtronic, Senko Medical Instrument, Xenios AG (Fresenius Medical Care Company) and others

What are the key opportunities?

• Key opportunities include increasing investment on healthcare infrastructure and use of centrifugal blood pumps in ECMO procedures